The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Biomimetic Nanotherapies: Red Blood Cell Based Core–Shell Structured Nanocomplexes for Atherosclerosis Management
Open accessAbstract
Cardiovascular disease is the leading cause of mortality worldwide. Atherosclerosis, one of the most common forms of the disease, is characterized by a gradual formation of atherosclerotic plaque, hardening, and narrowing of the arteries. Nanomaterials can serve as powerful delivery platforms for atherosclerosis treatment. However, their therapeutic efficacy is substantially limited in vivo due to nonspecific clearance by the mononuclear phagocytic system. In order to address this limitation, rapamycin (RAP)‐loaded poly(lactic‐co‐glycolic acid) (PLGA) nanoparticles are cloaked with the cell membrane of red blood cells (RBCs), creating superior nanocomplexes with a highly complex functionalized bio‐interface. The resulting biomimetic nanocomplexes exhibit a well‐defined “core–shell” structure with favorable hydrodynamic size and negative surface charge. More importantly, the biomimetic nature of the RBC interface results in less macrophage‐mediated phagocytosis in the blood and enhanced accumulation of nanoparticles in the established atherosclerotic plaques, thereby achieving targeted drug release. The biomimetic nanocomplexes significantly attenuate the progression of atherosclerosis. Additionally, the biomimetic nanotherapy approach also displays favorable safety properties. Overall, this study demonstrates the therapeutic advantages of biomimetic nanotherapy for atherosclerosis treatment, which holds considerable promise as a new generation of drug delivery system for safe and efficient management of atherosclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
Suk, J. S., Xu, Q., Kim, N., Hanes, J., & Ensign, L. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.012 · Cited by 4,523
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Inflammation in Atherosclerosis
Libby, P. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.179705 · Cited by 3,736
Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis
Gimbrone, M. A., & García-Cardeña, G. (2016) · Circulation Research · doi:10.1161/circresaha.115.306301 · Cited by 3,476
Macrophages in atherosclerosis: a dynamic balance
Moore, K. J., Sheedy, F. J., & Fisher, E. A. (2013) · Nature reviews. Immunology · doi:10.1038/nri3520 · Cited by 2,559
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform
Hu, C.-M. J., Zhang, L., Aryal, S., Cheung, C., Fang, R. H., & Zhang, L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106634108 · Cited by 2,433
Vascular smooth muscle cells in atherosclerosis
Bennett, M. R., Sinha, S., & Owens, G. K. (2016) · Circulation Research · doi:10.1161/circresaha.115.306361 · Cited by 2,179
Nanoparticle PEGylation for Imaging and Therapy
Jokerst, J. V., Lobovkina, T., Zare, R. N., & Gambhir, S. S. (2011) · Nanomedicine · doi:10.2217/nnm.11.19 · Cited by 2,046
Cell Membrane Coating Nanotechnology
Fang, R. H., Kroll, A. V., Gao, W., & Zhang, L. (2018) · Advanced Materials · doi:10.1002/adma.201706759 · Cited by 1,885
Nanoparticle biointerfacing by platelet membrane cloaking
Hu, C.-M. J., Fang, R. H., Wang, K.-C., Luk, B. T., Thamphiwatana, S., Dehaini, D., Nguyen, P., Angsantikul, P., Wen, C. H., Kroll, A. V., et al. (2015) · Nature · doi:10.1038/nature15373 · Cited by 1,789
Self-citationMatrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly.
Galis, Z. S., & Khatri, J. J. (2002) · PubMed · Cited by 1,787
Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: The Good, the Bad, and the Ugly
Galis, Z. S., & Khatri, J. J. (2002) · Circulation Research · doi:10.1161/res.90.3.251 · Cited by 1,548
Macrophage Phenotype and Function in Different Stages of Atherosclerosis
Tabas, I., & Bornfeldt, K. E. (2016) · Circulation Research · doi:10.1161/circresaha.115.306256 · Cited by 1,121
Minimal "Self" Peptides That Inhibit Phagocytic Clearance and Enhance Delivery of Nanoparticles
Rodriguez, P. L., Harada, T., Christian, D. A., Pantano, D. A., Tsai, R. K., & Discher, D. E. (2013) · Science · doi:10.1126/science.1229568 · Cited by 985
Zhang, Q., Dehaini, D., Zhang, Y., Zhou, J., Chen, X., Zhang, L., Fang, R. H., Gao, W., & Zhang, L. (2018) · Nature Nanotechnology · doi:10.1038/s41565-018-0254-4 · Cited by 958
Liposomes Coated with Isolated Macrophage Membrane Can Target Lung Metastasis of Breast Cancer
Cao, H., Dan, Z., He, X., Zhang, Z., Yu, H., Yin, Q., & Li, Y. (2016) · ACS Nano · doi:10.1021/acsnano.6b03148 · Cited by 694
Anti‐ PEG immunity: emergence, characteristics, and unaddressed questions
Yang, Q., & Lai, S. K. (2015) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1339 · Cited by 593
Gao, M., Liang, C., Song, X., Chen, Q., Jin, Q., Wang, C., & Liu, Z. (2017) · Advanced Materials · doi:10.1002/adma.201701429 · Cited by 590
Recent Advances in Cell Membrane–Camouflaged Nanoparticles for Cancer Phototherapy
Zhen, X., Cheng, P., & Pu, K. (2019) · Small · doi:10.1002/smll.201804105 · Cited by 483
Cell or Cell Membrane-Based Drug Delivery Systems
Tan, S., Wu, T., Zhang, D., & Zhang, Z. (2015) · Theranostics · doi:10.7150/thno.11852 · Cited by 466
Zhang, L., Wang, Z., Zhang, Y., Cao, F., Dong, K., Ren, J., & Qu, X. (2018) · ACS Nano · doi:10.1021/acsnano.8b05200 · Cited by 446
Self-citationVascular bursts enhance permeability of tumour blood vessels and improve nanoparticle delivery
Matsumoto, Y., Nichols, J. W., Toh, K., Nomoto, T., Cabral, H., Miura, Y., Christie, R. J., Yamada, N., Ogura, T., Kano, M. R., et al. (2016) · Nature Nanotechnology · doi:10.1038/nnano.2015.342 · Cited by 412
Interfacial interactions between natural RBC membranes and synthetic polymeric nanoparticles
Luk, B. T., Jack Hu, C.-M., Fang, R. H., Dehaini, D., Carpenter, C., Gao, W., & Zhang, L. (2013) · Nanoscale · doi:10.1039/c3nr06371b · Cited by 375
Synthesis and Biomedical Applications of Multifunctional Nanoparticles
Kim, D., Shin, K., Kwon, S. G., & Hyeon, T. (2018) · Advanced Materials · doi:10.1002/adma.201802309 · Cited by 317
Preparation and Application of Cell Membrane-Camouflaged Nanoparticles for Cancer Therapy
Zhai, Y., Su, J., Ran, W., Zhang, P., Yin, Q., Zhang, Z., Yu, H., & Li, Y. (2017) · Theranostics · doi:10.7150/thno.20118 · Cited by 312
Cell‐Membrane‐Coated Synthetic Nanomotors for Effective Biodetoxification
Wu, Z., Li, T., Gao, W., Xu, T., Jurado‐Sánchez, B., Li, J., Gao, W., He, Q., Zhang, L., & Wang, J. (2015) · Advanced Functional Materials · doi:10.1002/adfm.201501050 · Cited by 257
Self-citationSu, J., Sun, H., Meng, Q., Yin, Q., Tang, S., Zhang, P., Chen, Y., Zhang, Z., Yu, H., & Li, Y. (2016) · Advanced Functional Materials · doi:10.1002/adfm.201504780 · Cited by 220
Simamora, P., Alvarez, J. M., & Yalkowsky, S. H. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00617-7 · Cited by 211
Accelerated Blood Clearance Phenomenon Upon Repeated Injection of PEG-modified PLA-nanoparticles
Ishihara, T., Takeda, M., Sakamoto, H., Kimoto, A., Kobayashi, C., Takasaki, N., Yuki, K., Tanaka, K.-I., Takenaga, M., Igarashi, R., et al. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9943-x · Cited by 195
Probing nanoparticle translocation across the permeable endothelium in experimental atherosclerosis
Kim, Y., Lobatto, M. E., Kawahara, T., Lee Chung, B., Mieszawska, A. J., Sanchez-Gaytan, B. L., Fay, F., Senders, M. L., Calcagno, C., Becraft, J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322725111 · Cited by 189
Leveraging Physiology for Precision Drug Delivery
Sun, W., Hu, Q., Ji, W., Wright, G., & Gu, Z. (2017) · Physiological Reviews · doi:10.1152/physrev.00015.2016 · Cited by 169
Design of nanocarriers based on complex biological barriers in vivo for tumor therapy
Liu, J., Li, M., Luo, Z. Y., Dai, L., Guo, X., & Cai, K. (2017) · Nano Today · doi:10.1016/j.nantod.2017.06.010 · Cited by 158
Advances in lipid-lowering therapy through gene-silencing technologies
Nordestgaard, B. G., Nicholls, S. J., Langsted, A., Ray, K. K., & Tybjærg‐Hansen, A. (2018) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2018.3 · Cited by 148
Detection and treatment of atherosclerosis using nanoparticles
Zhang, J., Zu, Y., Dhanasekara, C. S., Li, J., Wu, D., Fan, Z., & Wang, S. F. (2016) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1412 · Cited by 134
Lobatto, M. E., Calcagno, C., Millon, A., Senders, M. L., Fay, F., Robson, P. M., Ramachandran, S., Binderup, T., Paridaans, M. P. M., Sensarn, S., et al. (2015) · ACS Nano · doi:10.1021/nn506750r · Cited by 133
Novel anti-inflammatory therapies for the treatment of atherosclerosis
Khan, R., Spagnoli, V., Tardif, J., & L’Allier, P. L. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.04.783 · Cited by 130
Hu, T., Yang, J., Cui, K., Rao, Q., Yin, T., Tan, L., Zhang, Y., Li, Z., & Wang, G. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b01993 · Cited by 120
Self-citationRed Blood Cells for Drug Delivery
Yan, J., Yu, J., Wang, C., & Gu, Z. (2017) · Small Methods · doi:10.1002/smtd.201700270 · Cited by 93
Recent Advances of Membrane-Cloaked Nanoplatforms for Biomedical Applications
Ai, X., Hu, M., Wang, Z., Zhang, W., Li, J., Yang, H., Lin, J., & Xing, B. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00103 · Cited by 78
Gao, L., Wang, H., Nan, L., Peng, T., Sun, L., Zhou, J., Xiao, Y., Wang, J., Sun, J., Lu, W., et al. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00428 · Cited by 64
Self-citationFrenning, G. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00338-9 · Cited by 63
Impact of Matrix Metalloproteinases on Atherosclerosis
Lin, J., Kakkar, V. V., & Lu, X. (2014) · Current Drug Targets · doi:10.2174/1389450115666140211115805 · Cited by 57
Mechanistic/mammalian target of rapamycin: Recent pathological aspects and inhibitors
Abdel‐Maksoud, M. S., El–Gamal, M. I., Benhalilou, D. R., Ashraf, S., Mohammed, S. A., & Oh, C. (2018) · Medicinal Research Reviews · doi:10.1002/med.21535 · Cited by 45
Preparation of Particulate Polymeric Therapeutics for Medical Applications
Zhuang, J., Fang, R. H., & Zhang, L. (2017) · Small Methods · doi:10.1002/smtd.201700147 · Cited by 42
Lewis, D. R., Petersen, L. K., York, A. W., Ahuja, S., Chae, H., Joseph, L. B., Rahimi, S. A., Uhrich, K. E., Haser, P. B., & Moghe, P. V. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv237 · Cited by 36
Progress and prospects of endothelial progenitor cell therapy in coronary stent implantation
Lan, H., Wang, Y., Yin, T., Wang, Y., Liu, W., Zhang, X., Yu, Q., Wang, Z., & Wang, G. (2015) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.33398 · Cited by 27
Self-citationDou, Y., Zhang, X., Xu, X., Zhou, X. W., Han, S., Wang, R., Su, M., Li, X., & Zhang, J. (2015) · Journal of Materials Chemistry B · doi:10.1039/c5tb01474c · Cited by 11
Cited by
Polymeric Nanoparticles for Drug Delivery
Beach, M. A., Nayanathara, U., Gao, Y., Zhang, C., Xiong, Y., Wang, Y., & Such, G. K. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00705 · Cited by 1,155
Self-citationGao, C., Huang, Q., Liu, C., Kwong, C. H. T., Yue, L., Wan, J.-B., Lee, S. M. Y., & Wang, R. (2020) · Nature Communications · doi:10.1038/s41467-020-16439-7 · Cited by 630
Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis
Chen, W., Schilperoort, M., Cao, Y., Shi, J., Tabas, I., & Tao, W. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00629-x · Cited by 518
Wang, Y., Zhang, K., Li, T., Maruf, A., Qin, X., Luo, L., Zhong, Y., Qiu, J., McGinty, S., Pontrelli, G., et al. (2021) · Theranostics · doi:10.7150/thno.47841 · Cited by 409
Self-citationCell Membrane Coating Technology: A Promising Strategy for Biomedical Applications
Liu, Y., Luo, J., Chen, X., Liu, W., & Chen, T. (2019) · Nano-Micro Letters · doi:10.1007/s40820-019-0330-9 · Cited by 408
Metadata
- Authors
- Wang, Y., Zhang, K., Qin, X., Li, T., Qiu, J., Yin, T., Huang, J., McGinty, S., Pontrelli, G., Ren, J., Wang, Q., Wu, W., & Wang, G.
- Venue
- Advanced Science
- Publisher
- Wiley
- Published
- 2019-04-24
- Volume
- 6
- Issue
- 12
- Pages
- 1900172-1900172
- ISSN
- 2198-3844 (ISSN-L)
- OpenAlex
- W2942187120
- Cited by
- 314
- References
- 49
- FWCI
- 9.73
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.